Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Figge

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
American Journal of Obstetrics and Gynecology|June 1, 1990
Stage IA2 squamous carcinoma of the cervix: difficult diagnosis and therapeutic dilemmaB E Greer, D C Figge, H K Tamimi, et al.
Obstetrics and Gynecology|June 1, 1988
Glassy cell carcinoma of the cervix redefinedH K Tamimi, M Ek, J Hesla, et al.
Journal of Neurology|December 1, 1991
Two cases of cerebral toxoplasmosis in AIDS patients mimicking HIV-related dementiaG Arendt, H Hefter, C Figge, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1984
Adjuvant postoperative pelvic radiation for carcinoma of the uterine cervix: pattern of cancer recurrence in patients undergoing elective radiation following radical hysterectomy and pelvic lymphadenectomyA H Russell, D Y Tong, D C Figge, et al.
Gynecologic Oncology|September 1, 1990
Gynecologic radiotherapy fields defined by intraoperative measurementsB E Greer, W J Koh, D C Figge, et al.
American Journal of Obstetrics and Gynecology|June 1, 1992
The utility of immunocytochemistry in invasive adenocarcinoma of the cervixH K Tamimi, A M Gown, J Kim-Deobald, et al.
Gynecologic Oncology|December 1, 1994
Primary central nervous system recurrence after paclitaxel therapy for epithelial ovarian malignancyV L Seewaldt, D C Figge, B E Greer, et al.
American Journal of Obstetrics and Gynecology|June 1, 1996
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancerJ M Cain, C Collins, S Petersdorf, et al.
Obstetrics and Gynecology|September 1, 1981
Estrogen replacement therapyH L Judd, R E Cleary, W T Creasman, et al.
American Journal of Obstetrics and Gynecology|June 1, 1994
Paclitaxel (Taxol) treatment for refractory ovarian cancer: phase II clinical trialV L Seewaldt, B E Greer, J M Cain, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
American Journal of Obstetrics and Gynecology|June 1, 1990
Stage IA2 squamous carcinoma of the cervix: difficult diagnosis and therapeutic dilemmaB E Greer, D C Figge, H K Tamimi, et al.
Obstetrics and Gynecology|June 1, 1988
Glassy cell carcinoma of the cervix redefinedH K Tamimi, M Ek, J Hesla, et al.
Journal of Neurology|December 1, 1991
Two cases of cerebral toxoplasmosis in AIDS patients mimicking HIV-related dementiaG Arendt, H Hefter, C Figge, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1984
Adjuvant postoperative pelvic radiation for carcinoma of the uterine cervix: pattern of cancer recurrence in patients undergoing elective radiation following radical hysterectomy and pelvic lymphadenectomyA H Russell, D Y Tong, D C Figge, et al.
Gynecologic Oncology|September 1, 1990
Gynecologic radiotherapy fields defined by intraoperative measurementsB E Greer, W J Koh, D C Figge, et al.
American Journal of Obstetrics and Gynecology|June 1, 1992
The utility of immunocytochemistry in invasive adenocarcinoma of the cervixH K Tamimi, A M Gown, J Kim-Deobald, et al.
Gynecologic Oncology|December 1, 1994
Primary central nervous system recurrence after paclitaxel therapy for epithelial ovarian malignancyV L Seewaldt, D C Figge, B E Greer, et al.
American Journal of Obstetrics and Gynecology|June 1, 1996
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancerJ M Cain, C Collins, S Petersdorf, et al.
Obstetrics and Gynecology|September 1, 1981
Estrogen replacement therapyH L Judd, R E Cleary, W T Creasman, et al.
American Journal of Obstetrics and Gynecology|June 1, 1994
Paclitaxel (Taxol) treatment for refractory ovarian cancer: phase II clinical trialV L Seewaldt, B E Greer, J M Cain, et al.
Pageof 4